• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec18
Femasys Inc. Obtains FDA Approval for FemVue Controlled Device
14:15
Nov15
Femasys released FY2025 9 Months Earnings on November 14, 2025 (EST) with actual revenue of USD 1.48 M and EPS of USD -0.4955
04:00
Femasys released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 729.39K (forecast USD 1.35M), actual EPS USD -0.1022 (forecast USD -0.115)
04:00
Nov3
Femasys Inc. Obtains FDA Approval to Commence Recruitment for FINALE Trial's Final Stage
13:30
Aug9
Femasys released FY2025 Semi-Annual earnings on August 8 (EST), actual revenue USD 750.53K, actual EPS USD -0.3878
03:00
Femasys released FY2025 Q2 earnings on August 8 (EST), actual revenue USD 409.27K (forecast USD 1.169M), actual EPS USD -0.16 (forecast USD -0.1625)
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 729.39 K, Net Income -4.195 M, EPS -0.1022

Aug8
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 409.27 K, Net Income -4.586 M, EPS -0.1587

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 341.26 K, Net Income -5.897 M, EPS -0.2344

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More